Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20737027 | 0.93 | AHR (0.34) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL20737769 | 0.93 | AHR (0.32) | AHR | |
| SCHEMBL25661403 | 0.93 | AHR (0.31) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL20736153 | 0.93 | AHR (0.33) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL25661581 | 0.93 | KDM4E (0.33) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL25661375 | 0.93 | AHR (0.31) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL25661603 | 0.93 | KDM4E (0.33) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL20737252 | 0.91 | — | — | |
| SCHEMBL25661703 | 0.91 | AHR (0.31) | AHRMEN1MAPTKMT2AKDM4E | |
| SCHEMBL25661683 | 0.91 | AHR (0.31) | AHRMEN1MAPTKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12022728-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-12022728-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-11552251-B2 | Organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-10 | — | — | US | disclosed |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11552251-B2 | Organic electroluminescent element and electronic device | L1CAM, ESR1, LEF1 | AHR 1405/4885MEN1 635/4885MAPT 1713/4885 |
| US-20190051835-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | L1CAM, ESR1, LEF1 | AHR 1405/4885MEN1 635/4885MAPT 1713/4885 |
| US-12022728-B2 | Organic electroluminescent element and electronic device | L1CAM, ESR1, LEF1 | AHR 1405/4885MEN1 635/4885MAPT 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.